The worldwide antacid medications market size was esteemed at USD 5.83 billion in 2017 and is projected to grow at a CAGR of 3.9% over the conjecture period. Changing dietary propensities is one of the central points expected to fuel development during the estimated time frame.
The expanding pervasiveness of Gastro-Esophageal Reflux Diseases (GERD) is required to influence the general market over the gauge time frame. As per the Gut diary, distributed by the International Foundation for Gastrointestinal Disorders; in 2017, the pervasiveness of GERD was around 18% to 28% in North America, 9% to 26% in Europe, 3% to 8% in East Asia, 9% to 33% in the Middle East, 12% in Australia, and 23% in South America.
Besides, expanding mindfulness about GERD is expected to support the antacid medications market. As indicated by an article distributed in the International Foundation for Gastrointestinal Disorders, the nineteenth Annual GERD Awareness Week was in November 2018 which gave data and backing in regard to this condition. Additionally, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) energizes patients experiencing GERD-related manifestations, to counsel their doctors... Read more